| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| Revenue | $4.35B | +13.1% |
| Cost of Revenue | $2.27B | +10.1% |
| Gross Profit | $2.08B | +16.7% |
| R&D Expense | $140.2M | +37.0% |
| SG&A Expense | $1.48B | +20.9% |
| Operating Income | $563.9M | +1.9% |
| Pre-tax Income | $500.2M | -8.8% |
| Income Tax | $103.6M | -17.8% |
| Net Income | $396.6M |
| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $422.5M | -50.0% |
| Accounts Receivable | $593.9M | +5.5% |
| Inventory | $526.7M | +35.9% |
| Current Assets | $1.65B | -11.8% |
| Total Assets | $4.76B | +24.7% |
| Current Liabilities | $845.8M | +23.0% |
| Long-term Debt | $896.8M | +80.7% |
| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $601.4M | -2.9% |
| Capital Expenditures | $68.4M | +6.9% |
| Investing Cash Flow | -$1.28B | -1867.3% |
| Financing Cash Flow | $255.4M | +344.4% |
| Free Cash Flow | $533.0M | -4.0% |
| -6.2% |
| EPS (Basic) | $12.85 | -6.1% |
| EPS (Diluted) | $12.53 | -6.8% |
| Total Liabilities |
| $2.03B |
| +41.4% |
| Stockholders' Equity | $2.72B | +14.5% |